Benzimidazole anthelmintic
Mebendazole
Selectively binds helminth β-, blocking formation and glucose uptake in susceptible intestinal nematodes.
Primary Mechanism of Action
Clinical / Scientific
Mebendazole inhibits helminth polymerization via β- binding, reducing glucose uptake and starving the parasite. Systemic exposure is typically lower than albendazole sulphoxide, which shapes its labelled intestinal-nematode use.
Pathway Targets
β-tubulin
Scientific explanation
disruption in susceptible nematodes.
Pathway Convergence
Clinical / Scientific
Target → pathway → downstream effect → biological consequence. This is a mechanistic map, not a treatment claim.
Intestinal nematode energy failure
Target to downstream effect: β-tubulin binding → Reduced glucose uptake → Parasite death or expulsion
Mechanistically Relevant Repurposed & Adjunctive Applications
Intestinal nematode infections
EstablishedMechanistic rationale
Established for labelled soil-transmitted helminth indications.
Experimental microtubule targeting in oncology models
PreclinicalMechanistic rationale
Mammalian data are preclinical and not established cancer therapy.
Mechanistic Application Matrix
| Biological Target | Mechanism | Potential Relevance | Evidence Level |
|---|---|---|---|
| β-tubulin | Polymerization inhibition | Helminth glucose handling | Established mechanism |
In Plain Language
Mebendazole damages the internal scaffolding of intestinal worms so they cannot absorb sugar and eventually die or pass out of the gut.
Compounds Sharing Pathways
Other library compounds whose structured pathway data overlap this ingredient. Shared pathways are not combination recommendations.
β-tubulin
Oncology Mechanistic Relevance
Cancers in the atlas where this compound has a mapped mechanistic rationale. Evidence tiers are not equivalent and do not imply treatment.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
disruption can trigger mitotic stress and in cell and animal models. This is not an established oncology use.
Mechanistic information is provided for scientific and educational purposes. Discussion of biological pathways or investigational applications does not establish clinical efficacy or constitute individualized medical advice.